N

Nanobiotix SA

Cambridge, United States Founded 2003 NASDAQ: NBTX

About

Clinical-stage nanomedicine company developing first-in-class radioenhancers using hafnium oxide nanoparticles

Company Details

Type
commercial
Employees
100-200
Funding
$300M+

Key Products

  • NBTXR3 (Hensify)
Visit Website

Related Companies